NYSE: ACH ACCENDRA HEALTH INC/VA/ 10-Q

ACH completes $375M divestiture, restructures debt as payor loss drives 39% EBITDA decline

Filed May 11, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 8, 2025 · ~2 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade ACH commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.